dc.creatorSchulte A.
dc.creatorWeber I.
dc.creatorFischer F.
dc.creatorTiga-Loza D.C.
dc.creatorAmaya Larios I.Y.
dc.creatorChihu L.
dc.creatorRamos-Castañeda J.
dc.creatorShepard D.S.
dc.creatorTschampl C.A.
dc.creatorUndurraga E.A.
dc.creatorUndurraga E.A.
dc.creatorMartínez-Vega R.A.
dc.creatorRamos-Castañeda J.
dc.creatorSchulte A.
dc.creatorWeber I.
dc.date.accessioned2024-01-10T14:23:35Z
dc.date.available2024-01-10T14:23:35Z
dc.date.created2024-01-10T14:23:35Z
dc.date.issued2020
dc.identifier10.3201/eid2604.190729
dc.identifier10806059
dc.identifier10806059 10806040
dc.identifierMEDLINE:32186487
dc.identifierSCOPUS_ID:85082022280
dc.identifierhttps://doi.org/10.3201/eid2604.190729
dc.identifierhttps://repositorio.uc.cl/handle/11534/80115
dc.identifierWOS:000524156300015
dc.description.abstract© 2020 Centers for Disease Control and Prevention (CDC). All rights reserved.We adapted the EQ-5D-3L questionnaire and visual analog scale to assess health-related quality of life (HRQOL) and persistent symptoms in 79 patients with laboratory-confirmed dengue in Morelos, Mexico. The lowest HRQOLs were 0.53 and 38.1 (febrile phase). Patients recovered baseline HRQOL in ≈2 months.
dc.languageen
dc.publisherCenters for Disease Control and Prevention (CDC)
dc.rightsregistro bibliográfico
dc.titleHealth-related quality of life after dengue fever, Morelos, Mexico, 2016–2017
dc.typeartículo de revisión


Este ítem pertenece a la siguiente institución